Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Heymann

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Lancet (London, England)|April 24, 2007
Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control studyNicholas C Grassly, Jay Wenger, Sunita Durrani, et al.
The Lancet. Planetary Health|June 9, 2018
The growth and strategic functioning of One Health networks: a systematic analysisMishal S Khan, Peregrine Rothman-Ostrow, Julia Spencer, et al.
Journal of Public Health Policy|April 13, 2022
Bridging global health actors and agendas: the role of national public health institutesSonja Myhre, Mahlet Kifle Habtemariam, David L Heymann, et al.
The Lancet. Infectious Diseases|July 21, 2020
Serology testing in the COVID-19 pandemic responseRosanna W Peeling, Catherine J Wedderburn, Patricia J Garcia, et al.
Lancet (London, England)|April 27, 2016
Yellow fever vaccine supply: a possible solutionThomas P Monath, Jack P Woodall, Duane J Gubler, et al.
Epidemiology and Infection|March 15, 2019
Syndromic surveillance: two decades experience of sustainable systems - its people not just data!Gillian E Smith, Alex J Elliot, Iain Lake, et al.
Ecohealth|November 15, 2017
A Qualitative Stakeholder Analysis of Avian Influenza Policy in BangladeshKaushik Chattopadhyay, Guillaume Fournié, Md Abul Kalam, et al.
Nature|January 17, 2012
Preventing pandemics: The fight over fluRon Fouchier, A B Osterhaus, John Steinbruner, et al.
Lancet (London, England)|August 2, 2016
UN High-Level Meeting on antimicrobials--what do we need?Ramanan Laxminarayan, Carlos F Amábile-Cuevas, Otto Cars, et al.
Lancet (London, England)|March 5, 2022
Travel measures in the SARS-CoV-2 variant era need clear objectivesAdam J Kucharski, Mark Jit, James G Logan, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Lancet (London, England)|April 24, 2007
Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control studyNicholas C Grassly, Jay Wenger, Sunita Durrani, et al.
The Lancet. Planetary Health|June 9, 2018
The growth and strategic functioning of One Health networks: a systematic analysisMishal S Khan, Peregrine Rothman-Ostrow, Julia Spencer, et al.
Journal of Public Health Policy|April 13, 2022
Bridging global health actors and agendas: the role of national public health institutesSonja Myhre, Mahlet Kifle Habtemariam, David L Heymann, et al.
The Lancet. Infectious Diseases|July 21, 2020
Serology testing in the COVID-19 pandemic responseRosanna W Peeling, Catherine J Wedderburn, Patricia J Garcia, et al.
Lancet (London, England)|April 27, 2016
Yellow fever vaccine supply: a possible solutionThomas P Monath, Jack P Woodall, Duane J Gubler, et al.
Epidemiology and Infection|March 15, 2019
Syndromic surveillance: two decades experience of sustainable systems - its people not just data!Gillian E Smith, Alex J Elliot, Iain Lake, et al.
Ecohealth|November 15, 2017
A Qualitative Stakeholder Analysis of Avian Influenza Policy in BangladeshKaushik Chattopadhyay, Guillaume Fournié, Md Abul Kalam, et al.
Nature|January 17, 2012
Preventing pandemics: The fight over fluRon Fouchier, A B Osterhaus, John Steinbruner, et al.
Lancet (London, England)|August 2, 2016
UN High-Level Meeting on antimicrobials--what do we need?Ramanan Laxminarayan, Carlos F Amábile-Cuevas, Otto Cars, et al.
Lancet (London, England)|March 5, 2022
Travel measures in the SARS-CoV-2 variant era need clear objectivesAdam J Kucharski, Mark Jit, James G Logan, et al.
Pageof 13